Drugmakers Mallinckrodt, Endo to Merge, Plan NYSE Listing
Mallinckrodt, Endo Merger to Create Diversified Pharmaceuticals Firm
Mallinckrodt plc (in examinership) Receives U.S. Court Approval for Financial Restructuring Plan
Mallinckrodt Announces Publication of Two Journal Manuscripts with Clinical and Economic Evidence for Acthar® Gel (Repository Corticotropin Injection)
Buxton Helmsley Issues Statement on Mallinckrodt plc. Bankruptcy Filing and Disclosures Revealing Apparently Concealed Intangible Asset Depreciation Expenses
The Law Offices of Frank R. Cruz Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)
Generic drugmakers start shipping copies of Takeda's ADHD drug Vyvanse
Mallinckrodt Receives U.S. FDA Approval for Lisdexamfetamine Dimesylate Capsules and Launches Product Used to Treat Attention-Deficit/Hyperactivity Disorder (ADHD)
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit
Mallinckrodt Receives Court Approval for "First Day" Motions to Support Ongoing Operations
NYSE American to Commence Delisting Proceedings Against Mallinckrodt plc (MNK)
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK
Mallinckrodt discloses grand jury subpoena, makes bankruptcy filing official
Drugmaker Mallinckrodt files for second bankruptcy in the US
Mallinckrodt plc Takes Next Step to Implement Comprehensive Financial Restructuring Plan to Address Long-Term Debt and Opioid Obligations
MALLINCKRODT SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options
Mallinckrodt stock tumbles on plans to file for Chapter 11 bankruptcy for second time in three years
MNK Stock Alert: Mallinckrodt Files for Bankruptcy Again
U.S. drugmaker Mallinckrodt plans to file for bankruptcy protection
Mallinckrodt to file for prepackaged Chapter 11 bankruptcy and cut about $1.9 billion in debt
Mallinckrodt plc Enters into Restructuring Support Agreement with Key Stakeholders on the Terms of a Prepackaged Financial Restructuring Plan
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit
MALLINCKRODT SHAREHOLDER ACTION REMINDER: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK
Buxton Helmsley Issues Letter to Mallinckrodt Plc. Directors Regarding Bankruptcy Negotiations and Financial Disclosure Violations
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK
Mallinckrodt plc Reports Second Quarter 2023 Financial Results and Reaffirms Full Year Guidance
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit
MNK Investors Have Opportunity to Lead Mallinckrodt plc Securities Fraud Lawsuit
Should You Buy Penny Stocks Right Now? 3 Reasons
Drugmaker Mallinckrodt in talks with hedge funds to avoid opioid settlements - WSJ
Hedge Funds Seek to Cut Off $1 Billion Meant for Opioid Victims
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK
Deadline Reminder: Law Offices of Howard G. Smith Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Mallinckrodt plc (MNK)
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc (MNK) Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Mallinckrodt plc (MNK) Investors
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors
INVESTOR ALERT: Law Offices of Howard G. Smith Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors
SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Mallinckrodt plc of Class Action Lawsuit and Upcoming Deadline - MNK
MALLINCKRODT DEADLINE ALERT: Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Mallinckrodt To Contact Him Directly To Discuss Their Options
The Law Offices of Frank R. Cruz Announces Investigation of Mallinckrodt plc (MNK) on Behalf of Investors
Mallinckrodt stock rises after disclosure of another one-week delay in the $200 million opioid-settlement payment
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Mallinckrodt plc Investors with Over $1 Million in Losses to Secure Counsel Before Important Deadline in Securities Class Action – MNK, MNKPF
Calling All Mallinckrodt plc (MNK) Investors: Contact Bronstein, Gewirtz & Grossman, LLC To Claim Your Losses!
Levi Strauss shares tumble on outlook cut, Mallinckrodt and Alibaba shares rise and more stocks on the move
Mallinckrodt open to proposed transactions as it struggles to pay opioid settlement; stock rallies
Mallinckrodt in Talks to Cut Opioid Settlement by Up to $1 Billion